A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy004 ◽

2018 ◽

Vol 48 (4) ◽

pp. 392-395 ◽

Author(s):

Kohei Nakachi ◽

Masaru Konishi ◽

Masafumi Ikeda ◽

Junki Mizusawa ◽

Junko Eba ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Download Full-text

Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv213 ◽

2016 ◽

Vol 46 (4) ◽

pp. 385-388 ◽

Author(s):

Junki Mizusawa ◽

Chigusa Morizane ◽

Takuji Okusaka ◽

Hiroshi Katayama ◽

Hiroshi Ishii ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Phase Iii Study

Download Full-text

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps4149 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS4149-TPS4149 ◽

Author(s):

Chigusa Morizane ◽

Takuji Okusaka ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

Makoto Ueno ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Phase Iii Study

Download Full-text

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4014 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4014-4014 ◽

Author(s):

Makoto Ueno ◽

Chigusa Morizane ◽

Takuji Okusaka ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Phase Iii Study

Download Full-text

Randomized Phase II Trial of Gemcitabine Plus S-1 Combination Therapy Versus S-1 in Advanced Biliary Tract Cancer: Results of the Japan Clinical Oncology Group Study (JCOG0805)

Annals of Oncology ◽

10.1093/annonc/mds548 ◽

2012 ◽

Vol 23 ◽

pp. xi15

Author(s):

M. Ikeda ◽

T. Okusaka ◽

J. Mizusawa ◽

A. Takashima ◽

C. Morizane ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ii Trial ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Study of Gemcitabine plus S-1 Combination Therapy vs. S-1 in Advanced Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG0805)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq110 ◽

2010 ◽

Vol 40 (12) ◽

pp. 1189-1191 ◽

Author(s):

A. Takashima ◽

C. Morizane ◽

H. Ishii ◽

K. Nakamura ◽

H. Fukuda ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

A Randomized Phase III Trial of Paclitaxel Plus Carboplatin (TC) Versus Paclitaxel Plus Cisplatin (TP) in Stage IVB or Recurrent Cervical Cancer: Japan Clinical Oncology Group Study (JCOG0505)

Annals of Oncology ◽

10.1016/s0923-7534(20)32358-9 ◽

2012 ◽

Vol 23 ◽

pp. xi126 ◽

Author(s):

R. Kitagawa ◽

N. Katsumata ◽

T. Shibata ◽

T. Nakanishi ◽

S. Nishimura ◽

...

Keyword(s):

Cervical Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Recurrent Cervical Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Download Full-text

A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv012 ◽

2015 ◽

Vol 45 (5) ◽

pp. 494-498 ◽

Author(s):

K. Kataoka ◽

T. Tsushima ◽

J. Mizusawa ◽

S. Hironaka ◽

Y. Tsubosa ◽

...

Keyword(s):

Esophageal Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Weekly Docetaxel ◽

Randomized Controlled ◽

Design And Methods

Download Full-text

A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv178 ◽

2016 ◽

Vol 46 (2) ◽

pp. 174-177 ◽

Author(s):

Kozo Kataoka ◽

Hiroya Takeuchi ◽

Junki Mizusawa ◽

Masahiko Ando ◽

Yasuhiro Tsubosa ◽

...

Keyword(s):

Esophageal Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Thoracic Esophageal Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Open Esophagectomy

Download Full-text

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyx063 ◽

2017 ◽

Vol 47 (7) ◽

pp. 664-667 ◽

Author(s):

Kenjiro Namikawa ◽

Arata Tsutsumida ◽

Tomonori Mizutani ◽

Taro Shibata ◽

Tatsuya Takenouchi ◽

...

Keyword(s):

Adjuvant Therapy ◽

Clinical Oncology ◽

Cutaneous Melanoma ◽

Interferon Beta ◽

Stage Ii ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4046 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4046-4046 ◽

Author(s):

Yoshiaki Iwasaki ◽

Masanori Terashima ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

Kenichi Nakamura ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Download Full-text